Advertisement
ResearchIn-Press PreviewAIDS/HIVAgingInflammation
Open Access | 10.1172/JCI187663
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Ramaswamy, S. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Akiyama, H. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Berrigan, J. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Quiñones-Molina, A. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by
Olson, A.
in:
PubMed
|
Google Scholar
|
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Chen, Y. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Liang, Y. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by
Henderson, A.
in:
PubMed
|
Google Scholar
|
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Asundi, A. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by Sagar, M. in: PubMed | Google Scholar
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, United States of America
2Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, United States of America
Find articles by
Gummuluru, S.
in:
PubMed
|
Google Scholar
|
Published June 10, 2025 - More info
Despite effective antiretroviral therapy (ART), transcriptionally competent HIV-1 reservoirs persist and contribute to persistent immune activation in people living with HIV (PWH). HIV-1-infected macrophages are important mediators of chronic innate immune activation, though mechanisms remain unclear. We previously reported that nuclear export and cytoplasmic expression of HIV-1 intron-containing RNA (icRNA) activates mitochondrial antiviral signaling protein (MAVS)-mediated type I interferon (IFN) responses in macrophages. In this study, we demonstrate an essential role of melanoma differentiation-associated protein 5 (MDA5) in sensing HIV-1 icRNA and promoting MAVS-dependent IRF5 activation in macrophages. Suppression of MDA5, but not RIG-I expression nor disruption of endosomal TLR pathway, abrogated HIV-1 icRNA-induced type I IFN responses and IP-10 expression in macrophages. Furthermore, induction of IP-10 in macrophages upon HIV-1 icRNA sensing by MDA5 was dependent on IRF5. Additionally, monocytes and MDMs from older (>50 years) individuals exhibit constitutively higher levels of IRF5 expression compared to younger (<35 years) individuals, and HIV-1 icRNA induced IP-10 expression was significantly enhanced in older macrophages, which was attenuated upon ablation of IRF5 expression suggesting that IRF5 functions as a major mediator of pro-inflammatory response downstream of MDA5-dependent HIV-1 icRNA sensing, dysregulation of which might contribute to chronic inflammation in older PWH.